• SPX
  • 6090.27
  • 0.25 %
  • 15.1602
  • DJI
  • 44642.52
  • -0.28 %
  • -123.1914
  • N225
  • 39091.17
  • -0.77 %
  • -304.4297
  • FTSE
  • 8308.61
  • -0.49 %
  • -40.7695
  • IXIC
  • 19859.773
  • 0.81 %
  • 159.0508
Cingulate Inc. (CINGW) Stock Price, News & Analysis

Cingulate Inc. (CINGW) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.0400

-$0

(-9.27%)

Day's range
$0.04
Day's range
$0.04
50-day range
$0.0199
Day's range
$0.0955
  • Country: US
  • ISIN: US17248W1137
52 wk range
$0.04
Day's range
$0.04
  • CEO: Dr. Shane J. Schaffer Pharm.D., PharmD
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 2,209.45
  • Piotroski Score 3.00
  • Grade N/A
  • Symbol (CINGW)
  • Company Cingulate Inc.
  • Price $0.04
  • Changes Percentage (-9.27%)
  • Change -$0
  • Day Low $0.04
  • Day High $0.04
  • Year High $0.04

Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of central nervous system and neurobiological disorders. The company's lead product candidates are CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine) for the treatment of attention deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas with an additional location in Morristown, New Jersey.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/30/2023
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$1.73
  • Trailing P/E Ratio -0.01
  • Forward P/E Ratio -0.01
  • P/E Growth -0.01
  • Net Income $-23,534,947

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Cingulate Inc. Frequently Asked Questions

  • What is the Cingulate Inc. stock price today?

    Today's price of Cingulate Inc. is $0.04 — it has decreased by -9.27% in the past 24 hours. Watch Cingulate Inc. stock price performance more closely on the chart.

  • Does Cingulate Inc. release reports?

    Yes, you can track Cingulate Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Cingulate Inc. stock forecast?

    Watch the Cingulate Inc. chart and read a more detailed Cingulate Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Cingulate Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Cingulate Inc. stock ticker.

  • How to buy Cingulate Inc. stocks?

    Like other stocks, CINGW shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Cingulate Inc.'s EBITDA?

    Cingulate Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Cingulate Inc.’s financial statements.

  • What is the Cingulate Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0, which equates to approximately 0.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Cingulate Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Cingulate Inc.'s financials relevant news, and technical analysis. Cingulate Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Cingulate Inc. stock currently indicates a “sell” signal. For more insights, review Cingulate Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.